| Ms Gina Glynn Mcclure, MS, CCC/SLP | |
|
500 S Independence St, Enid, OK 73701-5632 | |
| (580) 366-7110 | |
| Not Available |
| Full Name | Ms Gina Glynn Mcclure |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 500 S Independence St, Enid, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255530499 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 16896 (Texas) | Secondary |
| 235Z00000X | Speech-language Pathologist | 5284 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Gina Glynn Mcclure, MS, CCC/SLP 500 S Independence St, Enid, OK 73701-5632 Ph: (580) 366-7110 | Ms Gina Glynn Mcclure, MS, CCC/SLP 500 S Independence St, Enid, OK 73701-5632 Ph: (580) 366-7110 |
News Archive
In the quest to detect more types of cancers at ever earlier stages, researchers have been stymied by a lack of cell surface markers that distinguish in a clear-cut manner between healthy and malignant cells.
The results from the randomized, double -blind, placebo -controlled, Phase II EPOC (Endothelin A Proof Of Concept) Study of ZD4054 - a specific endothelin A (ETA) receptor antagonist – were delivered at the 14th European Congress of Clinical Oncology (ECCO, 23-27 September, Barcelona).
Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.
While cities have shown considerable racial disparities in cancer survival, those racial disparities virtually disappear among smaller populations, such as neighborhoods within that city.
According to research conducted at the Oregon National Primate Research Center at Oregon Health & Science University, the commonly held belief that oral contraceptives cause weight gain appears to be false. The results of the study are published online and will appear in next month's edition of the journal Human Reproduction.
› Verified 7 days ago
Emily E Buller, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Randolph Ave, Enid, OK 73701 Phone: 580-234-3734 Fax: 580-234-3554 | |
Sarah White, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 305 S 5th St, Enid, OK 73701 Phone: 580-233-6100 | |
Paula J Weaver, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Randolph Ave, Enid, OK 73701 Phone: 580-234-3734 Fax: 580-234-3554 | |
Lori Ann Tydings, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2102 Beverly Dr, Enid, OK 73703 Phone: 580-366-7650 | |
Nicole Celeste Fogtman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Randolph Ave, Enid, OK 73701 Phone: 412-420-7164 Fax: 580-234-2615 | |
Jessica L Lathem, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Randolph Ave, Enid, OK 73701 Phone: 580-234-3734 Fax: 580-234-2615 |